FDA Approved: RECARBRIO — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved RECARBRIO (imipenem/cilastatin/relebactam) under NDA 212819 from Merck Sharp & Dohme LLC, marking the original approval of this antibiotic combinat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Recarbrio (imipenem/cilastatin/relebactam)

Snippet

ORIG AP for RECARBRIO (IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS)